Dear distinguished guests, ladies and gentlemen,

On behalf of the organizing committee, it is my pleasure to welcome you to the 11th Antibody Therapeutic Conference (ATC) - the 2024 Antibody Therapeutics Conference: Extended Applications of Antibodies. The conference will be held on May 23rd-24th, 2024 at the National Biotechnology Research Park in Taipei, Taiwan.

In recent years, the field of antibody therapeutics has experienced significant growth, particularly in the areas of cancer treatment, immune-mediated diseases, and infectious diseases. Immunotherapies such as antibody-mediated tumor regression, checkpoint blockade, antibody-drug conjugates (ADC), and chimeric antigen receptor T-cell therapy (CAR-T), have emerged as promising strategies for curing many different cancers.

This year, the ATC will showcase a broad scope of remarkable achievements, with a focus on the extended application of antibodies as well as new therapeutic modalities for treatment of human diseases. We aim to provide a platform for participants to connect, communicate, gain new knowledge, and discuss the most recent advances in this field.

The Taiwan Antibody Association (TAA), the ATC organizer, was established in 2012 with a mission to facilitate research and industrial development of antibody drugs and related technologies in Taiwan. By hosting international conferences like this one, we hope to promote the exchange of ideas and foster collaborations between senior experts and young scientists in the field.

We sincerely hope that this conference will be informative and insightful, and that it will inspire you to make meaningful contributions to the advancement of antibody therapeutics. Once again, we thank you for joining us, and we wish you a successful and enjoyable conference experience.